Spanish (IBEX) Pharma Industry Analysis

UpdatedDec 14, 2025

DataAggregated Company Financials

Companies5

7D2.8%
3M10.5%
1Y24.3%
YTDn/a

The Pharma industry is up 2.8% in the last week, with Laboratorios Farmaceuticos Rovi up 4.0%. In the last 12 months, the industry was up 24%. Earnings are forecast to grow by 24% annually.

Industry Valuation and Performance

Has the Spanish Pharma Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Sun, 14 Dec 2025	€7.8b	€2.8b	€273.4m	36.4x	28.4x	2.8x
Tue, 11 Nov 2025	€7.1b	€2.8b	€252.7m	34.3x	28x	2.6x
Thu, 09 Oct 2025	€7.2b	€2.7b	€265.3m	31.1x	27.1x	2.7x
Sat, 06 Sep 2025	€7.0b	€2.7b	€265.3m	29.4x	26.3x	2.6x
Mon, 04 Aug 2025	€6.5b	€2.7b	€265.3m	29.1x	24.5x	2.4x
Wed, 02 Jul 2025	€6.7b	€2.7b	€284.5m	21.3x	23.7x	2.5x
Fri, 30 May 2025	€6.6b	€2.7b	€284.5m	21.4x	23.3x	2.5x
Sun, 27 Apr 2025	€6.2b	€2.7b	€267.7m	20.7x	23.3x	2.3x
Tue, 25 Mar 2025	€6.2b	€2.7b	€267.7m	19.9x	23.1x	2.3x
Thu, 20 Feb 2025	€6.1b	€2.7b	€226.1m	16.9x	27x	2.3x
Sat, 18 Jan 2025	€6.2b	€2.7b	€226.1m	18.7x	27.5x	2.3x
Mon, 16 Dec 2024	€6.2b	€2.7b	€226.1m	19.2x	27.6x	2.4x
Wed, 13 Nov 2024	€6.5b	€2.6b	€235.9m	20.3x	27.4x	2.5x
Fri, 11 Oct 2024	€7.1b	€2.5b	€219.5m	25.2x	32.2x	2.8x
Sun, 08 Sep 2024	€7.3b	€2.5b	€219.5m	23.6x	33.4x	2.9x
Tue, 06 Aug 2024	€7.1b	€2.5b	€219.5m	23.3x	32.3x	2.8x
Thu, 04 Jul 2024	€7.7b	€2.5b	€202.7m	24x	38x	3.1x
Sat, 01 Jun 2024	€8.0b	€2.6b	€193.1m	26.1x	41.6x	3.1x
Mon, 29 Apr 2024	€7.5b	€2.6b	€223.6m	21.6x	33.4x	2.9x
Wed, 27 Mar 2024	€7.1b	€2.6b	€223.6m	20.9x	31.5x	2.7x
Fri, 23 Feb 2024	€6.7b	€2.6b	€250.4m	15.5x	26.8x	2.6x
Sun, 21 Jan 2024	€6.3b	€2.6b	€296.4m	16.3x	21.3x	2.4x
Tue, 19 Dec 2023	€6.0b	€2.6b	€296.4m	15.8x	20.3x	2.3x
Thu, 16 Nov 2023	€5.6b	€2.5b	€305.3m	14.8x	18.3x	2.2x
Sat, 14 Oct 2023	€6.0b	€2.5b	€274.5m	15.3x	21.7x	2.4x
Mon, 11 Sep 2023	€5.9b	€2.5b	€274.5m	14.8x	21.6x	2.4x
Wed, 09 Aug 2023	€5.6b	€2.5b	€274.5m	13.4x	20.3x	2.3x
Fri, 07 Jul 2023	€4.7b	€2.4b	€284.3m	11.1x	16.6x	2x
Sun, 04 Jun 2023	€5.0b	€2.4b	€284.3m	11.5x	17.7x	2.1x
Tue, 02 May 2023	€5.0b	€2.4b	€301.6m	17.8x	16.7x	2.1x
Thu, 30 Mar 2023	€4.8b	€2.4b	€301.6m	17.1x	15.9x	2x
Sat, 25 Feb 2023	€5.2b	€2.4b	€294.7m	30.8x	17.6x	2.2x
Mon, 23 Jan 2023	€4.9b	€2.3b	€275.8m	28.7x	17.7x	2.1x
Wed, 21 Dec 2022	€4.8b	€2.3b	€275.8m	27.8x	17.4x	2x

Price to Earnings Ratio

17.4x

Wed, 21 Dec 2022

Current Industry PE

Investors are optimistic on the Spanish Pharmaceuticals industry, and appear confident in long term growth rates.

The industry is trading at a PE ratio of 28.4x which is higher than its 3-year average PE of 25.1x.

The 3-year average PS ratio of 2.5x is lower than the industry's current PS ratio of 2.8x.

Past Earnings Growth

The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
Meanwhile revenues for these companies have grown 5.8% per year.
This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Comparison

How does Spanish Pharma compare with similar industries?


ES Market	0.68%
Healthcare	1.29%
Pharma	2.85%
Pharma	2.85%

Industry PEThere are no additional sub-industries under this industry.

Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company	Last Price	7D	1Y	Valuation
ROVI Laboratorios Farmaceuticos Rovi	€62.25	4.0% +€122.8m	0.3%	PE26.3x
ALM Almirall	€13.22	2.0% +€55.8m	58.5%	PE67.5x
FAE Faes Farma	€4.81	2.8% +€40.5m	40.5%	PE14.2x